Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -4 of 4 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 11/1/2000


1.		Phase II Study of Antibiotics and Gastric Acid Inhibition for Gastric MALT Lymphoma (Summary Last Modified 11/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 to 80				NCI				MDA-CPPDM-95084 NCI-T95-0003D, NCT00002682, T95-0003

Last Modified: 4/1/1999


2.		Phase II Trial of Antibiotic Eradication of Helicobacter Pylori and, Failing That, Local Therapy with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) and Involved Field Radiation in Patients with Mucosa Associated Lymphoid Tissue (MALT) Lymphomas (Summary Last Modified 04/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				SWOG-9703 S9703

Last Modified: 5/1/2000 First Published: 1/1/1998


3.		Phase II Study of Anti-Helicobacter pylori Treatment in Endoscopically Diagnosed Low Grade Localized Gastric Lymphoma (Summary Last Modified 05/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over								EORTC-20961 CRC-EORTC-20961, HOVON-33, NCT00003151

Last Modified: 7/10/2007 First Published: 8/19/2005


4.		Randomized Study of Omeprazole and Amoxicillin and/or Vitamin and Mineral Supplementation Comprising Vitamin E, Ascorbic Acid, and Selenium and/or Garlic Supplementation to Inhibit Progression Towards Gastric Cancer in Patients With Precancerous Gastric Lesions

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Prevention				Closed				35 to 65				NCI				NCI-OH-95-C-N029 BICR-OH95-C-N029, NCT00134121

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute